CorEvitas
Acquired by Thermo Fisher Scientific
Is this your company?
CorEvitas is now part of Thermo Fisher Scientific. For up-to-date information, please see the Thermo Fisher Scientific profile..
Find the right fit for you - faster
Get tailored insights about working at CorEvitas in one quick step.
CorEvitas Snapshot
CorEvitas is a science-driven, healthcare company fueled by real world data and analytics. CorEvitas provides a holistic approach to capturing real-world data through patient-centered solutions including clinical registries, patient insight studies, biospecimen solutions and specialty electronic health record (EHR) data. Leveraging these data and analytic services, CorEvitas helps biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators.
CorEvitas' data are considered the gold standard in observational research and have been used in over 140 peer reviewed manuscripts and 430 abstracts. CorEvitas has conducted active safety surveillance to support regulatory commitments for 14 new drug approvals, including formal post authorization safety studies.
CorEvitas operates eight major autoimmune and inflammatory registries across the US, Canada, and Japan, collecting data from nearly 500 clinical sites. HealthiVibe, the patient experience team, complements and strengthens our disease registries by providing market-leading expertise in supporting innovative, evidence-based patient engagement initiatives across the entire product lifecycle. Our HealthUnlocked technology platform hosts over 1.4 million patients in hundreds of condition-specific communities and significantly enhances the depth and breadth of patient experiential data. Through our Health iQ unit, CorEvitas has access to a broad range of UK-based and international data sets enabling us to understand market access issues, including clinical utilization, capacity planning, and cost optimization. Vestrum Health, a leader in data analytics of retinal practice EHR, provides insightful views of retinal diseases across the drug life cycle. CorEvitas is an Audax Private Equity portfolio company.
CorEvitas is proud to provide equal employment opportunities to all qualified individuals without regard to race, color, religion, sex, gender identity, sexual orientation, pregnancy, age, national origin, physical or mental disability, military or veteran status, genetic information, or any other protected classification. Minorities, women, LGBTQ candidates, Veterans, and individuals with disabilities are encouraged to apply.
CorEvitas' data are considered the gold standard in observational research and have been used in over 140 peer reviewed manuscripts and 430 abstracts. CorEvitas has conducted active safety surveillance to support regulatory commitments for 14 new drug approvals, including formal post authorization safety studies.
CorEvitas operates eight major autoimmune and inflammatory registries across the US, Canada, and Japan, collecting data from nearly 500 clinical sites. HealthiVibe, the patient experience team, complements and strengthens our disease registries by providing market-leading expertise in supporting innovative, evidence-based patient engagement initiatives across the entire product lifecycle. Our HealthUnlocked technology platform hosts over 1.4 million patients in hundreds of condition-specific communities and significantly enhances the depth and breadth of patient experiential data. Through our Health iQ unit, CorEvitas has access to a broad range of UK-based and international data sets enabling us to understand market access issues, including clinical utilization, capacity planning, and cost optimization. Vestrum Health, a leader in data analytics of retinal practice EHR, provides insightful views of retinal diseases across the drug life cycle. CorEvitas is an Audax Private Equity portfolio company.
CorEvitas is proud to provide equal employment opportunities to all qualified individuals without regard to race, color, religion, sex, gender identity, sexual orientation, pregnancy, age, national origin, physical or mental disability, military or veteran status, genetic information, or any other protected classification. Minorities, women, LGBTQ candidates, Veterans, and individuals with disabilities are encouraged to apply.
